# C.N. Ho

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/c-n-ho/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7 |
| Field | Eosinophilic Esophagitis |
| h-index | 2 |
| i10-index | 0 |
| Last Known Institution | China Medical University |
| OpenAlex ID | https://openalex.org/A5028743514 |
| ORCID iD | 0000-0002-4618-869X |
| Works | 8 |

## Researcher papers

- [The Early Dynamic Change in Cardiac Enzymes and Renal Function Is Associated with Mortality in Patients with Fulminant Myocarditis on Extracorporeal Membrane Oxygenation: Analysis of a Single Center’s Experience](https://scholariq.org/papers/the-early-dynamic-change-in-cardiac-enzymes-and-renal-function-is-associated/)
- [A Comparison of the Short-Term Outcomes After use of Aorto-Uni-Iliac Versus Bifurcated Endografts for Endovascular Repair of Ruptured Abdominal Aortic Aneurysms](https://scholariq.org/papers/a-comparison-of-the-short-term-outcomes-after-use-of-aorto-uni-iliac-versus/)
- [Efficacy of Benralizumab in Reducing Cough Frequency and Improving Health-Related Quality of Life in Patients With Severe Eosinophilic Asthma in Asia: A Post-hoc Analysis of the Phase 3 Miracle Study](https://scholariq.org/papers/efficacy-of-benralizumab-in-reducing-cough-frequency-and-improving-health/)
- [A PHARMACIST/RN SUPERVISED MEDICATION TITRATION PROGRAM TO ACHIEVE HEART RATE/ RHYTHM CONTROL IN ATRIAL FIBRILLATION: A RETROSPECTIVE CHART REVIEW (PARTNER-AF)](https://scholariq.org/papers/a-pharmacist-rn-supervised-medication-titration-program-to-achieve-heart-rate/)
- [372: Factors Related to Mortality in Patients With Myocarditis Requiring VA ECMO: A Retrospective Study](https://scholariq.org/papers/372-factors-related-to-mortality-in-patients-with-myocarditis-requiring-va-ecmo/)
- [Two-year Efficacy and Safety of Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis](https://scholariq.org/papers/two-year-efficacy-and-safety-of-benralizumab-in-the-treatment-of-eosinophilic/)
- [OP0166 EFFICACY AND SAFETY OF TWO YEARS OF TREATMENT WITH ANTI-IL-5/R THERAPIES FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS](https://scholariq.org/papers/op0166-efficacy-and-safety-of-two-years-of-treatment-with-anti-il-5-r-therapies/)
- [Evaluation of endovascular procedures for abdominal false lumen repair in patients with post-dissection aortic aneurysm](https://scholariq.org/papers/evaluation-of-endovascular-procedures-for-abdominal-false-lumen-repair-in/)

## Researcher topics

- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Aortic Disease and Treatment Approaches](https://scholariq.org/topics/aortic-disease-and-treatment-approaches/)
- [Aortic aneurysm repair treatments](https://scholariq.org/topics/aortic-aneurysm-repair-treatments/)
- [Viral Infections and Immunology Research](https://scholariq.org/topics/viral-infections-and-immunology-research/)
- [Infectious Aortic and Vascular Conditions](https://scholariq.org/topics/infectious-aortic-and-vascular-conditions/)

## Researcher university

- [China Medical University](https://scholariq.org/institutions/china-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
